HIGHLIGHTS
- who: Angelina Konnova and colleagues from the University of Texas Southwestern Medical Center, United States have published the research: Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors, in the Journal: (JOURNAL) of February/15,/2021
- what: The authors propose a blood-based signature of cytokines/chemokines and growth factors that can be employed in identifying cancer patients at persistent high-risk of COVID-19 despite vaccination with BNT162b2. 3.3 CRP, IL-15, IL-18, and PlGF predict a poor BNT162b2 immune_response in cancer patients Due to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.